Cargando…

Unique features of central neuropathic pain in multiple sclerosis: Results of a cluster analysis

BACKGROUND: Central neuropathic pain (CNP) is an excruciating condition, prevalent in up to a third of patients with multiple sclerosis (MS). Identifying CNP among MS patients is particularly challenging considering the ample comorbid chronic pain conditions and sensory disturbances entailed by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivel, Michal, Achiron, Anat, Dolev, Mark, Stern, Yael, Zeilig, Gabi, Defrin, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313873/ https://www.ncbi.nlm.nih.gov/pubmed/35263811 http://dx.doi.org/10.1002/ejp.1934

Ejemplares similares

A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort
por: Kalron, Alon, et al.
Publicado: (2015)

Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis
por: Gurevich, Michael, et al.
Publicado: (2015)

Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis
por: Achiron, Anat, et al.
Publicado: (2012)

Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis
por: Kalron, Alon, et al.
Publicado: (2016)

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study
por: Harari, Gil, et al.
Publicado: (2023)

Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study
por: Achiron, Anat, et al.
Publicado: (2013)

Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients
por: Menascu, Shay, et al.
Publicado: (2020)

Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Cognitive function in multiple sclerosis: A long-term look on the bright side
por: Harel, Yermi, et al.
Publicado: (2019)

The Design, Development, and Testing of a Virtual Reality Device for Upper Limb Training in People With Multiple Sclerosis: Single-Center Feasibility Study
por: Kalron, Alon, et al.
Publicado: (2022)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
por: Achiron, Anat, et al.
Publicado: (2021)

Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online survey
por: Kalron, Alon, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis
por: Menascu, Shay, et al.
Publicado: (2023)

Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a
por: Menascu, Shay, et al.
Publicado: (2021)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Central Neuropathic Pain and Profiles of Quantitative Electroencephalography in Multiple Sclerosis Patients
por: Krupina, Nataliya A., et al.
Publicado: (2020)

Unique Gene Expression Patterns in Human T-cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide
por: Mandel, Mathilda, et al.
Publicado: (2005)

Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
por: Kaminski, Naftali, et al.
Publicado: (2005)

Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
por: Kopsky, David J., et al.
Publicado: (2012)

Optimizing multiple sclerosis diagnosis: gene expression and genomic association
por: Gurevich, Michael, et al.
Publicado: (2015)

Injury to white matter tracts in relapsing–remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics
por: Asaf, Achiron, et al.
Publicado: (2015)

Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
por: Achiron, Anat, et al.
Publicado: (2009)

Botulinum Toxin for Central Neuropathic Pain
por: Park, Jihye, et al.
Publicado: (2018)

Review of the Treatments for Central Neuropathic Pain
por: Sheldon, Breanna L., et al.
Publicado: (2022)

Understanding Autoimmune Mechanisms in Multiple Sclerosis Using Gene Expression Microarrays: Treatment Effect and Cytokine-related Pathways
por: Achiron, A., et al.
Publicado: (2004)

Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Short‐ and long‐term effects of conventional spinal cord stimulation on chronic pain and health perceptions: A longitudinal controlled trial
por: Brill, Silviu, et al.
Publicado: (2022)

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod
por: Achiron, Anat, et al.
Publicado: (2022)

Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis
por: Blecher, Tal, et al.
Publicado: (2019)

Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study
por: Kalron, Alon, et al.
Publicado: (2016)

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Quantifying Gait Impairment Using an Instrumented Treadmill in People with Multiple Sclerosis
por: Kalron, Alon, et al.
Publicado: (2013)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

Pain perception in people with Down syndrome: a synthesis of clinical and experimental research
por: McGuire, Brian E., et al.
Publicado: (2015)

Therapeutic Approaches for Peripheral and Central Neuropathic Pain
por: Szok, Délia, et al.
Publicado: (2019)

Evaluation of Neuropathic Extremity Pain in Patients with Multiple Sclerosis
por: ATA, Emre, et al.
Publicado: (2019)

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
por: Achiron, Anat, et al.
Publicado: (2023)

Longitudinal relationships between disability and gait characteristics in people with MS
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Rehab-let: touchscreen tablet for self-training impaired dexterity post stroke: study protocol for a pilot randomized controlled trial
por: Rand, Debbie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aguq1hguug134gmh0lkt8ustmu